| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |